Dr. Juan Espinosa Pereiro

Institutions of which it is part

General Hospital

Accident and Emergency Department

Cross-departmental services

Infectious Diseases

Doctor

Juan Espinosa Pereiro, graduated in Medicine from the University of Santiago de Compostela. Specialist in Internal Medicine and Infectious Diseases at the H. U. Vall d'Hebrón, in Barcelona. He is a researcher and clinical member of the International Health Program of the Catalan Institute of Health. Collaborating researcher in the EUSAT-RCS and EU-PEARL projects. He also participates in several competitive projects within the national scope. Member of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and within them their respective mycobacteria study groups (GEIM and ESGMYC, respectively). He has participated in the publication of several scientific articles in the field of Infectious Diseases, including tuberculosis, Chagas disease and COVID-19.

Curriculum

EDUCATION
2007-2013: Degree with Extraordinary Award in Medicine. Universidade de Santiago de Compostela.
PhD candidate: “Mycobacterium tuberculosis resistance to and optimization of first line drugs.” October 2019 to present: Universitat Autónoma de Barcelona, Barcelona, Cataluña, Spain. Director: Adrián Sánchez-Montalvá.
Residence May 2014 -May 2019: Internal Medicine. Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Cataluña, Spain.
Subspecialization May 2017 to May 2019: Infectious Diseases. Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Cataluña, Spain.
Internships November-December 2018: Tropical Diseases Oxford University Clinical Research Unit Vietnam, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
October-December 2019 and June-July 2022: Tuberculosis Instituto de Enfermedades Respiratorias y del Ambiente (INERAM), Asunción, Paraguay. Programa Nacional de Control de la Tuberculosis (PNCT), Asunción Paraguay.

PROFESSIONAL EXPERIENCE
Licensed Physician number 50420, in Barcelona, 2014.
May 2019 to present: Emergency Department, attending physician.
May 2019 to present: Global Health and Tropical Diseases.

RESEARCH EXPERIENCE
Competitive grants participation:
November 2019 to present: Pre-doctoral Research Fellow at EU Patient-cEntric clinical tRial pLatform (EU-PEARL). Grant number 853966.
May 2019 to present: Pre-doctoral Research Fellow at European-Latin American TB Research Collaboration Network (EUSAT-RCS). Grant number: 823890.
Good clinical practice certificate: until April 23rd 2023.

PUBLICATIONS
First-author:
A restrospective study on the influence of sibling’s relatedness in Bolivian patients with
chronic Chagas disease. Parasites and Vectors. 2019 12:260
MDR Tuberculosis Treatment. Medicina (Kaunas). 2022 Jan 26;58(2):188. doi: 10.3390/medicina58020188.

Co-authored:
Ulcers on psoriatic plaques in a patient with advanced Human Immunodeficiency Virus infection. Enfermedades Infecciosas y Microbiología clínica, 2017 Nov;35(9):605-606. PMID 27240445.
Mixed connective tissue disease and epitope spreading: An Historical Cohort Study. Journal of Clinical Rheumatology. 2017 Apr;23(3): 155-159. PMID 28248800.
Usefulness of FDG PET/CT in the management of tuberculosis. PLoS ONE. 2019 14 (8): e0221516
Tigecycline-associated hypofibrinogenemia in a real-world setting. International Journal of Clinical Pharmacology. 2020 Aug;42(4):1184-1189. PMID: 32504166.
Blastocystis sp. carriage and irritable bowel syndrome: is the association already established? Biology. 2021, 10, 340.
Risk of SARS-COV-2 infection in previously infected and non-infected cohorts of health workers at high risk of exposure. Journal of Clinical Medicine. 2021 April, 10, 1968.
Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab. Medicina Clinica. 2021 Jun 18:S0025-7753(21)00360-2. PMID: 34544604.
Impact of the COVID-19 pandemic on tuberculosis management in Spain. International Journal of Infectious Diseases. 2021 Jul;108:300-305. PMID: 33930543. Imported cystic echinococcosis in Spain: a systematic review. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2021 Oct 1;115(10):1184-1189. PMID: 33631003.

Other publications
Guía práctica de actuación en epidemias de COVID-19 en residencias para personas mayores. [Practical actuation guideline for COVID-19 epidemics in nursing facilities]. Sociedad Española de Medicina de Familia y Comunitaria. Enero 2021.
Juan Espinosa Pereiro

Institutions

General Hospital

Accident and Emergency Department

Cross-departmental services

Infectious Diseases

Doctor

Vall Hebron Institut de Recerca

Predoctoral researcher

Infectious Diseases

Notícies relacionades

Professionals

Subscribe to our newsletters and be a part of Campus Life

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.